• There are no suggestions because the search field is empty.
Information Officer - Regulatory Affairs - QbD Group

Information Officer

QbD Group provides pharmaceutical organizations with a qualified Information Officer to coordinate and monitor the corporate’s information management and marketing activities. 

 

Managing your information

How far are pharmaceutical companies allowed to go when advertising their products? Which information must be communicated in a summary of product characteristics? 

 

To be fully compliant with legal requirements, a qualified expert has to take responsibility over how information on pharmaceuticals is communicated and marketed. 

 Responsibilities of an Information Officer:

  • They must have a solid understanding of the medical and scientific field to apply all relevant guidelines appropriately.
  • They are responsible for ensuring that labeling, package inserts, product information, and advertising for a product align with its approval or registration.
  • They need to create product information, instructions for use, and mandatory text.
  • They bear the responsibility for maintaining up-to-date instructions for use, product information, and mandatory text.
  • They must stay informed about relevant changes in  regulations, laws, and deadlines and implement them accordingly.
  • They coordinate with the relevant authorities as needed.
  • They conduct training sessions to raise awareness among sales and marketing personnel about applicable legal regulations.

 

How we support you

Pharmaceutical companies operate within strict legal frameworks when it comes to communicating and marketing their products. To avoid risks and ensure compliance, a qualified Information Officer plays a pivotal role in managing and overseeing all product-related communication.

 

Here’s what makes this role indispensable:

Industry expertise

Our team brings years of experience in the pharmaceutical and life sciences sectors, ensuring you receive tailored guidance to meet regulatory expectations.

Comprehensive solutions

We ensure all your materials meet legal requirements, including:

  • Labeling: clear, accurate, and compliant product labels.
  • Patient Information Leaflets (PIL): informative and accessible materials for patients.
  • Summary of Product Characteristics (SmPC): detailed, accurate product descriptions for healthcare professionals.
  • Advertising materials: fully compliant promotional content, such as adverts, brochures, and displays.

Empower your team

Through targeted training sessions, we equip your sales and marketing teams with the knowledge to navigate legal boundaries confidently and effectively.
portrait image - website (28)

Why partner with QbD Group?

EXCEPTIONAL RA SERVICES THAT MEET YOUR NEEDS​ 

Choosing QbD Group means partnering with a trusted leader in Regulatory Affairs. With over a decade of expertise, we provide tailored support across the entire product lifecycle, ensuring seamless compliance and customer satisfaction on a global scale.

  • 10+ years of experience: benefit from our team of highly qualified consultants. ​
  • Full life cycle support: full support from pre- to the post-marketing phase.​
  • Global presence​: QbD Group operates globally, at QbD Austria with a special focus on Europe (EU) and China.​
  • Customer satisfaction​: constant evaluation, transparency and clear objectives.​ 
doc-mask

Related content

preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Blog

Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) under the MDR: Ensuring safety and performance

With the introduction of the Medical Device Regulation (MDR), the...
preview_image
Blog

What Makes Usability Testing Crucial for Near-Patient and Self-Testing Devices under IVDR?

It shouldn’t be a surprise that today, “Near-Patient Testing (NPT)” and...
preview_image
Blog

When does Annex XIV apply in Performance Studies, and what key documentation is needed for compliance?

In the European regulatory landscape, conducting performance studies for in...
preview_image
Blog

What are the requirements for IVD Clinical Performance Studies Under IVDR and ISO 20916?

What is a Clinical Performance Study? A clinical performance study...

 

contact-mail

Get in touch

Have questions about pharmaceutical advertising or regulatory compliance?

Our experts can help ensure your materials meet all legal requirements and standards. Contact us and we’ll guide you in navigating these complex regulations with confidence.














RA_Get in touch